NYSEARCA:IBDS iShares iBonds Dec 2027 Term Corporate ETF (IBDS) Price, Holdings, & News $24.26 +0.01 (+0.02%) As of 03:05 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOwnershipShort InterestBuy This Stock About iShares iBonds Dec 2027 Term Corporate ETF (NYSEARCA:IBDS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBDS alerts:Sign Up Key Stats Today's Range$24.25▼$24.2750-Day Range$24.11▼$24.2752-Week Range$23.86▼$24.68Volume280,806 shsAverage Volume601,346 shsMarket Capitalization$3.19 billionAssets Under Management$3.26 billionDividend Yield4.37%Net Expense Ratio0.10%Aggregate RatingN/A ETF Overview The iShares iBonds Dec 2027 Term Corporate ETF (IBDS) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg global index of USD-denominated, investment-grade corporate bonds maturing between December 31, 2026 and December 16, 2027. IBDS was launched on Sep 12, 2017 and is managed by BlackRock. Read More iShares iBonds Dec 2027 Term Corporate ETF ExpensesTypeIBDSInvestment Grade ETFsFixed Income ETFsNYSEARCA ETFsAll ETFsManagement Fee0.10%0.23%0.32%0.51%0.53%Other Expenses0.00%0.11%0.27%0.59%0.56%Total Expense0.10%0.25%0.40%0.74%0.73%Fee Waiver0.00%-0.14%-0.26%-0.71%-0.63%Net Expense0.10%0.23%0.35%0.58%0.60% Receive IBDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares iBonds Dec 2027 Term Corporate ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IBDS ETF News HeadlinesiShares iBonds Dec 2027 Term Muni Bond ETF declares monthly distribution of $0.0525August 4, 2025 | msn.comiShares iBonds Dec 2027 Term Corporate ETF declares monthly distribution of $0.0878August 4, 2025 | seekingalpha.comBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of the market’s most overlooked opportunities today. NanoViricides, Inc. (NYSE: NNVC) is advancing NV-387, a broad-spectrum antiviral now in human trials, with activity against COVID-19, RSV, influenza, measles, and most recently Mpox. With Phase II trials approved in Africa for the deadliest Mpox strain, the timing couldn’t be more critical.August 18 at 2:00 AM | Smallcaps Daily (Ad)iShares iBonds Dec 2027 Term Corporate ETFJune 19, 2025 | markets.businessinsider.comiShares iBonds Dec 2027 Term Corporate Breaks Below 200-Day Moving Average - Notable for IBDSJune 4, 2025 | nasdaq.comiShares iBonds Dec 2027 Term Corporate ETF declares monthly distribution of $0.0882June 3, 2025 | msn.comSee More Headlines IBDS ETF - Frequently Asked Questions How have IBDS shares performed this year? iShares iBonds Dec 2027 Term Corporate ETF's stock was trading at $23.96 at the beginning of 2025. Since then, IBDS shares have increased by 1.2% and is now trading at $24.2550. Who are iShares iBonds Dec 2027 Term Corporate ETF's major shareholders? Top institutional investors of iShares iBonds Dec 2027 Term Corporate ETF include Ameriprise Financial Inc. (1.14%), RVW Wealth LLC (0.79%), Captrust Financial Advisors (0.58%) and NewEdge Advisors LLC (0.47%). How do I buy shares of iShares iBonds Dec 2027 Term Corporate ETF? Shares of IBDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of iShares iBonds Dec 2027 Term Corporate ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that iShares iBonds Dec 2027 Term Corporate ETF investors own include Garmin (GRMN), Kinsale Capital Group (KNSL), WPP (WPP), Pan American Silver (PAAS), Principal Financial Group (PFG), Invesco NASDAQ 100 ETF (QQQM) and Vertex Pharmaceuticals (VRTX). Fund Details IssueriShares Fund NameiShares iBonds Dec 2027 Term Corporate ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IBDS Inception Date9/12/2017 Fund ManagerJames Mauro, Scott Radell WebN/A PhoneN/AFund Focus Asset ClassFixed Income BenchmarkBloomberg December 2027 Maturity Corporate Index CategoryCorporate FocusInvestment Grade Development LevelDeveloped Markets RegionNorth America Number of Holdings685 Fund Statistics Assets Under Management$3.26 billion Average Daily Volume$552.78 thousand Discount/Premium0.01% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorBlackRock Fund Advisors CustodianState Street Bank and Trust Company DistributorBlackRock Investments, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerVirtu Financial Options OptionableN/A Short Interest478,200 shs Miscellaneous Outstanding Shares131,500,000Beta0.23 Creation Unit50,000 Creation Fee$300.00 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report Top 10 IBDS HoldingsBLK CSH FND TREASURY SL AGENCYHolding Weight: 0.80%T-MOBILE USA INC - 3.75 2027-04-15Holding Weight: 0.72%CITIGROUP INC - 4.45 2027-09-29Holding Weight: 0.71%MICROSOFT CORPORATION - 3.3 2027-02-06Holding Weight: 0.64%AMAZON.COM INC - 3.15 2027-08-22Holding Weight: 0.60%GOLDMAN SACHS GROUP INC/THE - 3.85 2027-01-26Holding Weight: 0.54%BROADCOM CORPORATION/BROADCOM CAYM - 3.88 2027-01-15Holding Weight: 0.52%MORGAN STANLEY - 3.63 2027-01-20Holding Weight: 0.51%ORACLE CORPORATION - 3.25 2027-11-15Holding Weight: 0.48%ALIBABA GROUP HOLDING LTD - 3.4 2027-12-06Holding Weight: 0.46%Full Holdings DetailsIBDS Sector ExposureIBDS Industry Exposure This page (NYSEARCA:IBDS) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares iBonds Dec 2027 Term Corporate ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares iBonds Dec 2027 Term Corporate ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access